Dogwood Therapeutics, Inc. (DWTX) Stock Analysis

Dogwood Therapeutics, Inc. (DWTX) is a publicly traded company in the HEALTHCARE sector. It trades at $1.67, carries a market capitalization of $57.17M, a price-to-earnings ratio of 1.45. This page summarizes the public market data, fundamentals, and frequently asked questions for DWTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.67
• Market Cap: $57.17M
• P/E Ratio: 1.45
• EPS: $1.17
• 52-Week High: $9.50
• 52-Week Low: $1.28

Market Sentiment

Dogwood Therapeutics, Inc. currently has a Neutral sentiment score of 0.03.

About Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc. is a forward-thinking biotechnology company based in Alpharetta, Georgia, focused on pioneering antiviral therapies aimed at addressing diseases stemming from dysregulated immune responses to viral infections. With a promising pipeline of innovative therapeutic candidates, the company utilizes cutting-edge research to redefine treatment strategies in the field. As it progresses through the preclinical and clinical development phases, Dogwood Therapeutics is dedicate...

GNG Research Analysis

GNG Research scores Dogwood Therapeutics, Inc. (DWTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DWTX.

Frequently Asked Questions

Does DWTX pay dividends?

Dogwood Therapeutics, Inc. (DWTX) does not currently pay a regular dividend.

What is DWTX's P/E ratio?

Dogwood Therapeutics, Inc. has a price-to-earnings (P/E) ratio of 1.45.

What is DWTX's market cap?

Dogwood Therapeutics, Inc. (DWTX) has a market capitalization of $57.17M with a current stock price of $1.67.